Suppr超能文献

2019 年冠状病毒病与登革热:两例病例报告。

Coronavirus disease 2019 and dengue: two case reports.

机构信息

Department of Internal Medicine, Indira Gandhi Memorial Hospital, Male' 20002, Maldives.

Mahidol-Osaka Center for Infectious Diseases, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand.

出版信息

J Med Case Rep. 2021 Mar 26;15(1):171. doi: 10.1186/s13256-021-02707-7.

Abstract

BACKGROUND

The pandemic of this century has overwhelmed the healthcare systems of affected countries, and all resources have been diverted to coronavirus disease 2019. At the onset, coronavirus disease 2019 can present as any other acute febrile undifferentiated illness. In tropical regions, clinicians are increasingly challenged to differentiate these febrile illnesses without the use of diagnostics. With this pandemic, many of these tropical diseases are neglected and go underreported. Dengue is holoendemic in the Maldives, and dengue viruses circulate throughout the year. Reports about coinfections with dengue virus and severe acute respiratory syndrome coronavirus 2 are scarce, and the outcome and the dynamics of the disease may be altered in the presence of coinfection. We have described the clinical manifestation and serial laboratory profile, and highlighted the atypical findings uncommon in dengue infection.

CASE PRESENTATION

Case 1 was a 39-year old Asian male, presented on day 6 of dengue infection with warning signs. Reverse transcription polymerase chain reaction for severe acute respiratory syndrome coronavirus 2 that was done as per hospital protocol was found to be positive. Case 2 was a 38-year old Asian male, was admitted on day 5 of illness with symptoms of acute respiratory infection with positive reverse transcription polymerase chain reaction for severe acute respiratory syndrome coronavirus 2. Evaluation of progressive leukopenia and thrombocytopenia showed positive dengue serology.

CONCLUSION

Clinicians must be conscientious when working on the differential diagnosis of possible tropical diseases in cases of coronavirus disease 2019, specifically, when patients develop hemoconcentration, thrombocytopenia, and transaminitis with elevated expression of aspartate higher than alanine transaminase, which is frequently observed in dengue infection. Caution must be taken during the administration of intravenous fluids when treating patients with coronavirus disease 2019 and dengue coinfection, as coronavirus disease 2019 patients are more prone to develop pulmonary edema. Timely diagnosis and appropriate management are essential to avoid the devastating complications of severe forms of dengue infection. It is important to repeat and reconfirm the dengue serology in coronavirus disease 2019 patients to avoid false positivity. Diligence and care must be taken not to neglect other endemic tropical diseases in the region during the present pandemic.

摘要

背景

本世纪的大流行使受影响国家的医疗体系不堪重负,所有资源都转移到了 2019 年冠状病毒病上。起初,2019 年冠状病毒病可能表现为任何其他急性发热性未分化疾病。在热带地区,临床医生越来越难以在不使用诊断方法的情况下区分这些发热性疾病。随着这次大流行,许多热带疾病被忽视,报告不足。登革热在马尔代夫呈全流行态势,登革热病毒全年循环。关于登革热病毒与严重急性呼吸综合征冠状病毒 2 的合并感染的报告很少,合并感染可能改变疾病的结局和动态。我们描述了临床表现和连续实验室特征,并强调了登革热感染中不常见的非典型发现。

病例介绍

病例 1 是一名 39 岁的亚洲男性,在登革热感染第 6 天出现警告症状。根据医院方案进行的严重急性呼吸综合征冠状病毒 2 的逆转录聚合酶链反应检测结果呈阳性。病例 2 是一名 38 岁的亚洲男性,在发病第 5 天因急性呼吸道感染入院,严重急性呼吸综合征冠状病毒 2 的逆转录聚合酶链反应检测结果呈阳性。对进行性白细胞减少症和血小板减少症的评估显示登革热血清学阳性。

结论

临床医生在对 2019 年冠状病毒病进行可能的热带疾病的鉴别诊断时必须保持谨慎,特别是当患者出现血浓缩、血小板减少症和天门冬氨酸转氨酶升高的丙氨酸转氨酶时,这在登革热感染中经常观察到。在治疗 2019 年冠状病毒病和登革热合并感染的患者时,在给予静脉输液时必须谨慎,因为 2019 年冠状病毒病患者更易发生肺水肿。及时诊断和适当治疗对于避免严重登革热感染的并发症至关重要。在 2019 年冠状病毒病患者中,重复并重新确认登革热血清学检查以避免假阳性非常重要。在当前大流行期间,必须谨慎并注意不要忽视该地区的其他地方性热带疾病。

相似文献

1
Coronavirus disease 2019 and dengue: two case reports.
J Med Case Rep. 2021 Mar 26;15(1):171. doi: 10.1186/s13256-021-02707-7.
2
Focus on uncommon symptoms of COVID-19: Potential reason for spread of infection.
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1873-1874. doi: 10.1016/j.dsx.2020.09.017. Epub 2020 Sep 16.
3
Challenges of dengue and coronavirus disease 2019 coinfection: two case reports.
J Med Case Rep. 2021 Aug 30;15(1):439. doi: 10.1186/s13256-021-02973-5.
4
Clinical and Laboratory Profile of Dengue Fever.
J Assoc Physicians India. 2015 Dec;63(12):30-32.
5
Severe Acute Respiratory Syndrome Coronavirus 2 and Dengue Virus Co-infection: Indian Perspectives.
Disaster Med Public Health Prep. 2022 Oct;16(5):1769-1771. doi: 10.1017/dmp.2021.254. Epub 2021 Aug 4.
6
Case Report: Extrapulmonary Manifestations of COVID-19 and Dengue Coinfection.
Am J Trop Med Hyg. 2021 Jun 28;105(2):363-367. doi: 10.4269/ajtmh.21-0177.
7
COVID-19 Associated Multisystem Inflammatory Syndrome: A Systematic Review and Meta-analysis.
Iran J Allergy Asthma Immunol. 2020 Dec 19;19(6):570-588. doi: 10.18502/ijaai.v19i6.4927.
8
Clinical features and outcomes of COVID-19 and dengue co-infection: a systematic review.
BMC Infect Dis. 2021 Aug 2;21(1):729. doi: 10.1186/s12879-021-06409-9.
9
Distinguishing non severe cases of dengue from COVID-19 in the context of co-epidemics: A cohort study in a SARS-CoV-2 testing center on Reunion island.
PLoS Negl Trop Dis. 2021 Apr 26;15(4):e0008879. doi: 10.1371/journal.pntd.0008879. eCollection 2021 Apr.

引用本文的文献

2
The effects of the COVID-19 pandemic on dengue cases in Malaysia.
Front Public Health. 2023 Aug 24;11:1213514. doi: 10.3389/fpubh.2023.1213514. eCollection 2023.
3
Dengue and COVID-19 Co-Circulation in the Peruvian Amazon: A Population-Based Study.
Am J Trop Med Hyg. 2023 Apr 24;108(6):1249-1255. doi: 10.4269/ajtmh.22-0539. Print 2023 Jun 7.
4
Concurrent Infection with SARS-CoV-2 and during the COVID-19 Pandemic in the Maldives.
Trop Med Infect Dis. 2023 Jan 25;8(2):82. doi: 10.3390/tropicalmed8020082.
7
Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5-11 years: Correspondence.
Hum Vaccin Immunother. 2022 Dec 30;18(7):2149015. doi: 10.1080/21645515.2022.2149015. Epub 2022 Nov 20.
8
Black Fungus and beyond: COVID-19 associated infections.
Clin Imaging. 2022 Oct;90:97-109. doi: 10.1016/j.clinimag.2022.07.005. Epub 2022 Jul 23.
9
SARS-CoV-2 and dengue virus co-infection: Epidemiology, pathogenesis, diagnosis, treatment, and management.
Rev Med Virol. 2023 Jan;33(1):e2340. doi: 10.1002/rmv.2340. Epub 2022 Mar 3.
10
Mathematical models for dengue fever epidemiology: A 10-year systematic review.
Phys Life Rev. 2022 Mar;40:65-92. doi: 10.1016/j.plrev.2022.02.001. Epub 2022 Feb 15.

本文引用的文献

1
Coronavirus Disease of 2019: a Mimicker of Dengue Infection?
SN Compr Clin Med. 2020;2(8):1109-1119. doi: 10.1007/s42399-020-00364-3. Epub 2020 Jul 13.
2
Dengue serology in Indonesian COVID-19 patients: Coinfection or serological overlap?
IDCases. 2020 Aug 5;22:e00927. doi: 10.1016/j.idcr.2020.e00927. eCollection 2020.
3
Pneumococcal coinfection in COVID-19 patients.
J Med Virol. 2021 Jan;93(1):177-179. doi: 10.1002/jmv.26278. Epub 2020 Jul 17.
4
Coinfection, coepidemics of COVID-19, and dengue in dengue-endemic countries: A serious health concern.
J Med Virol. 2021 Jan;93(1):161-162. doi: 10.1002/jmv.26269. Epub 2020 Jul 14.
5
Chikungunya resurgence in the Maldives and risk for importation via tourists to Europe in 2019-2020: A GeoSentinel case series.
Travel Med Infect Dis. 2020 Jul-Aug;36:101814. doi: 10.1016/j.tmaid.2020.101814. Epub 2020 Jun 30.
6
Influenza and COVID-19 coinfection: Report of six cases and review of the literature.
J Med Virol. 2020 Nov;92(11):2657-2665. doi: 10.1002/jmv.26125. Epub 2020 Jun 29.
7
COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection.
Blood. 2020 Jul 23;136(4):489-500. doi: 10.1182/blood.2020006520.
9
Case Report: COVID-19 Presenting as Acute Undifferentiated Febrile Illness-A Tropical World Threat.
Am J Trop Med Hyg. 2020 Jul;103(1):83-85. doi: 10.4269/ajtmh.20-0440. Epub 2020 May 15.
10
A Case of COVID-19 and Coinfection.
Am J Respir Crit Care Med. 2020 Jul 1;202(1):136-138. doi: 10.1164/rccm.202003-0766LE.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验